MP Healthcare Venture Management
Cambridge, Massachusettsmp-healthcare.com
Overview
MP Healthcare Venture Management is the corporate venture capital arm of Mitsubishi Tanabe Pharma Corporation that invests in seed and early-stage biotech companies, primarily in North America and Europe, focusing on novel therapeutics, platform technologies, diagnostics, and vaccines.
Investments
| Company | Date | Stage | Lead |
|---|---|---|---|
| TRIMTECH Therapeutics | Jun 2026 | Seed | Co-investor |
| GlycoEra | May 2025 | Series B | Co-investor |
| TRIMTECH Therapeutics | Mar 2025 | Seed | Co-investor |
| LiberoThera Co., Ltd. | Aug 2024 | VC Round | Co-investor |
| Draupnir Bio | Jul 2024 | Seed | Lead |
Sector & Stage Mix
Industry, funding stage, and valuation band breakdowns.
